Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when LFWD files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsLifeward regains Nasdaq compliance after appointing three new audit committee members
Filed March 31, 2026 · Period ending March 30, 2026 · ~1 min read
Key Changes
-
medium
Nasdaq confirmed Lifeward is back in compliance with audit committee requirements after appointing Moshe Rozenbaum, William Mark Sigsbee, and Yehuda Reznick to the committee. The deficiency matter is now closed.
Item 8.01 verify on EDGAR → -
medium
The compliance issue arose when director Hadar Levy resigned, dropping the audit committee below the required three-member minimum. Nasdaq had given Lifeward until the earlier of its next annual meeting or February 2027 to fix the problem.
Item 8.01 verify on EDGAR →
Summary
Lifeward has resolved a Nasdaq listing compliance issue by expanding its audit committee back to the required minimum of three members. The problem emerged when board member Hadar Levy resigned, leaving the audit committee short-staffed. Nasdaq had issued a deficiency notice but gave the company time to cure the violation.
The company acted quickly, appointing three new members—Moshe Rozenbaum, William Mark Sigsbee, and Yehuda Reznick—to the audit committee. On March 30, 2026, Nasdaq confirmed the appointments satisfy listing requirements and closed the matter. For retail investors, this is routine housekeeping that removes a potential delisting risk, though the underlying reason for Levy's departure wasn't disclosed. Investors should watch for any additional board changes or governance updates in upcoming proxy materials, particularly details about the new audit committee members' qualifications and any explanation for the prior resignation.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR → · paraphrased
the Company received written notice (the "Notice") from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC (the "Staff") stating that the Company, as a result of the resignation of Hadar Levy from the Company's Board of Directors (the "Board") and its Audit Committee, no longer complied with Nasdaq Listing Rule 5605(c) (2) (A), which requires listed companies to have an audit committee of at least three members.
Lifeward had previously received a deficiency notice from Nasdaq after Hadar Levy's resignation reduced the Audit Committee below the required three-member minimum. Nasdaq provided a cure period extending to the earlier of the next annual meeting or February 24, 2027 (with an August 24, 2026 minimum if the annual meeting occurred before that date).
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify